Rankings
▼
Calendar
DNA Q4 2020 Earnings — Ginkgo Bioworks Holdings, Inc. Revenue & Financial Results | Market Cap Arena
DNA
Ginkgo Bioworks Holdings, Inc.
$418M
Q4 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$32M
Gross Profit
$18M
56.8% margin
Operating Income
-$56M
-174.3% margin
Net Income
-$47M
-146.4% margin
EPS (Diluted)
$-1.48
QoQ Revenue Growth
+141.0%
Cash Flow
Operating Cash Flow
-$59M
Free Cash Flow
-$79M
Stock-Based Comp.
$118,000
Balance Sheet
Total Assets
$675M
Total Liabilities
$205M
Stockholders' Equity
$461M
Cash & Equivalents
$381M
← FY 2020
All Quarters
Q1 2021 →
